Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Cash from Financing Activities (2019 - 2025)

Benitec Biopharma has reported Cash from Financing Activities over the past 6 years, most recently at $98.2 million for Q4 2025.

  • Quarterly results put Cash from Financing Activities at $98.2 million for Q4 2025, up 449.69% from a year ago — trailing twelve months through Dec 2025 was $129.2 million (up 62.3% YoY), and the annual figure for FY2025 was $70.5 million, up 3.61%.
  • Cash from Financing Activities reached $98.2 million in Q4 2025 per BNTC's latest filing, up from $2.5 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $98.2 million in Q4 2025 and bottomed at $3000.0 in Q1 2021.
  • Median Cash from Financing Activities over the past 5 years was $17.9 million (2024), compared with a mean of $24.1 million.
  • The largest annual shift saw Cash from Financing Activities skyrocketed 45720.51% in 2024 before it crashed 93.65% in 2025.
  • Over 5 years, Cash from Financing Activities stood at $12.7 million in 2021, then increased by 26.42% to $16.0 million in 2022, then tumbled by 99.76% to $39000.0 in 2023, then surged by 45720.51% to $17.9 million in 2024, then surged by 449.69% to $98.2 million in 2025.
  • Business Quant data shows Cash from Financing Activities for BNTC at $98.2 million in Q4 2025, $2.5 million in Q2 2025, and $28.4 million in Q1 2025.